Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
In men with prostate cancer who do not have evidence of spread to bone or other sites on
computed axial tomography (CAT) scan/bone scan but are still at significant risk of failing
treatment with surgery or radiation alone, a combination of chemotherapy and hormone therapy
is being given for 6 months followed by surgery to remove the prostate.
Phase:
Phase 2
Details
Lead Sponsor:
US Department of Veterans Affairs VA Office of Research and Development